Masimo (MASI) Total Debt (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -13.96% |
| Jan 3, 2026 | -7.35% |
| Sep 27, 2025 | -6.61% |
| Jun 28, 2025 | -5.86% |
| Mar 29, 2025 | -10.96% |
| Dec 28, 2024 | -2.58% |
| Sep 28, 2024 | -1.78% |
| Jun 29, 2024 | -11.28% |
| Mar 30, 2024 | -3.48% |
| Dec 30, 2023 | -4.22% |
| Sep 30, 2023 | 2.40% |
| Jul 1, 2023 | -0.97% |
| Apr 1, 2023 | -4.68% |
| Dec 31, 2022 | -1.03% |
| Oct 1, 2022 | 3.14% |
| Oct 1, 2016 | -12.89% |
| Jul 2, 2016 | -22.22% |
| Apr 2, 2016 | 21.57% |
| Jan 2, 2016 | -2.65% |
| Oct 3, 2015 | 7.03% |
| Jul 4, 2015 | 41.93% |
| Apr 4, 2015 | -0.03% |
| Jan 3, 2015 | -0.01% |
| Sep 27, 2014 | 66.44% |